A role for interleukin-1 receptor antagonism in severe COVID-19?
Lancet Rheumatol
.
2021 Oct;3(10):e672-e673.
doi: 10.1016/S2665-9913(21)00249-6.
Epub 2021 Aug 9.
Authors
Rachel S Tattersall
1
,
Dennis McGonagle
2
,
Jessica J Manson
3
Affiliations
1
Department of Rheumatology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
2
Leeds Institute of Rheumatic and Musculoskeletal Medicine (LIRMM), University of Leeds, Leeds, UK.
3
Department of Rheumatology, University College London Hospitals NHS Foundation Trust, London, UK.
PMID:
34396155
PMCID:
PMC8352494
DOI:
10.1016/S2665-9913(21)00249-6
No abstract available